Posted on by ScienceFather
67 / 100
Powered by Rank Math SEO

Yanxia Jin | Genetics | Best Scholar Award

Associate Professor at Hubei Normal University, China.

Dr. Yanxia Jin is a distinguished associate professor at Hubei Normal University, specializing in biomedical sciences, particularly in cancer treatment and tumorigenesis. Known for her dedication to both research and teaching, she actively mentors graduate students, fostering their growth in life sciences. Her work has received significant recognition through various prestigious awards and honors. Dr. Jin has contributed extensively to the field with over 38 SCI-indexed publications, including numerous first-author and corresponding author roles. Her leadership in high-impact research and commitment to academic excellence make her a valuable asset to the scientific and academic communities.

Publication Profile

Scopus

Educational Background

Dr. Jin has a robust academic foundation in biomedical sciences, which she has furthered through postdoctoral research at prominent institutions. Her postdoctoral studies at Zhongnan Hospital of Wuhan University and Hong Kong Baptist University allowed her to specialize in clinical medicine and traditional Chinese pharmacy. Her educational background has equipped her with a unique blend of interdisciplinary knowledge that she has applied throughout her research and teaching career. This solid academic and research training has set the groundwork for her impactful contributions to cancer research and the life sciences.

Experience

With years of experience as an academic mentor and researcher, Dr. Jin has become a pivotal figure at Hubei Normal University. She has not only led critical projects as Principal Investigator but also collaborated on nationally funded initiatives, such as those supported by the National Natural Science Foundation of China (NSFC) and the Hubei Province Natural Science Foundation. Her experience spans research project management, scientific publication, and graduate mentorship. Her work has established her as a leading expert in her field, contributing to advancements in cancer treatment and biomedical sciences.

Research Focus

Dr. Jinā€™s research focuses on understanding tumorigenesis and developing innovative cancer treatment approaches. Her work with selenium nanocomposites, biomarker identification, and anti-tumor compounds has shown promise in targeting lung cancer and leukemia. This specialization in molecular oncology and nanomedicine underlines her commitment to addressing pressing health challenges. Dr. Jinā€™s studies are driven by a goal to translate foundational research into clinical applications, reflecting her dedication to advancing treatment options and improving patient outcomes in oncology.

Awards and honors

Dr. Jin has received several notable awards, including recognition as both a Chutian Scholar and a Hong Kong Scholar, celebrating her contributions to biomedical research and education. Her accomplishments are further highlighted by her leadership in prestigious research projects funded by major foundations. These accolades underscore her dedication to her field and her impact on cancer research and biomedical sciences. Dr. Jinā€™s honors not only mark her as a researcher of high repute but also as a dedicated educator who inspires the next generation of scientists.

Conclusion

Dr. Yanxia Jin’s exemplary achievements, including her high-impact research, significant grant funding, and dedication to mentorship, make her an exceptional candidate for the Best Scholar Award. Her work on innovative cancer treatments and biomarkers exemplifies her commitment to addressing complex health challenges. With her ongoing dedication to expanding her research and mentorship, Dr. Jin is well-suited to receive this award, embodying both excellence in scholarship and significant contributions to the field of life sciences.

Publication Top Notes

Title: A novel selenium nanocomposite modified by AANL inhibits tumor growth by upregulating CLK2 in lung cancer
Authors: Zhang, Y., Chen, Y., Wang, B., Pan, J., Jin, Y.
Year: 2024
Citations: 0

Title: A diagnostic biomarker of acid glycoprotein 1 for distinguishing malignant from benign pulmonary lesions
Authors: Chen, Y., Zhang, Y., Huang, A., Pan, J., Jin, Y.
Year: 2023
Citations: 0

Title: Preparation and usage of nanomaterials in biomedicine
Authors: Zhang, Y., Ai, L., Gong, Y., Jin, Y.
Year: 2023
Citations: 3

Title: Overexpression of SERPINA3 suppresses tumor progression by modulating SPOP/NF-ĪŗB in lung cancer
Authors: Jin, Y., Zhang, Y., Huang, A., Wang, W., Pan, J.
Year: 2023
Citations: 3

Title: Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases
Authors: Jin, Y., Wang, W., Wang, Q., Raza, U., Gong, Y.
Year: 2022
Citations: 27

Title: Evaluation of prognostic staging systems of multiple myeloma in the era of novel agents
Authors: Shang, Y., Jin, Y., Liu, H., Hu, J., Zhou, F.
Year: 2022
Citations: 2

Title: Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency
Authors: Jiang, H., Jin, Y., Shang, Y., Gong, F., Zhou, F.
Year: 2021
Citations: 3

Title: Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver
Authors: Ye, X., Wang, X., Yu, W., Xu, B., Sun, H.
Year: 2021
Citations: 4

Title: Shengxuening Extracted from Silkworm Excrement Mitigates Myelosuppression via SCF-Mediated JAK2/STAT3 Signaling
Authors: Ding, L., Tan, Y., Xu, L., Huang, T., Zhou, F.
Year: 2021
Citations: 8

Yanxia Jin | Genetics | Best Scholar Award

You May Also Like